INBS:NASDAQ, Intelligent Bio Solutions Inc.
INBS stock overview
Intelligent Bio Solutions Inc. (INBS:NASDAQ) closed at $1.69 on October 22, 2026,
down 2.60% on the day.
The stock trades 93.2% below its 52-week high of $24.90
and 24.8% above its 52-week low of $1.35.
Over the past year, it lost 83.5%.
Intelligent Bio Solutions Inc. is part of the Health Care sector.
Key figures
- Price
- $1.69
- Day change
- -2.60%
- Volume
- 7,877
- Average volume
- 146,309
- Market cap
- 5M+
- 52-week range
- $1.35 – $24.90
- 50-day average
- $2.03
- 200-day average
- $3.58
Price action over the past year
In 252 trading sessions since October 22, 2025, INBS closed higher on 83 days (33%).
Its best day was December 31, 2025 (+132.44%) and its worst was January 21, 2026 (-28.53%).
The stock moved 10% or more in a single session 27 times.
It opened at least 5% above the previous day's high 3 times.
Recent signals
INBS news
-
Sep 10, 2026:
Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET
-
Sep 9, 2026:
Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market
-
Sep 9, 2026:
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
-
Sep 1, 2026:
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
-
Sep 1, 2026:
Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules
-
Aug 19, 2026:
Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth
-
Aug 17, 2026:
Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification
-
Aug 11, 2026:
Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System
About Intelligent Bio Solutions Inc.
GBS Inc is a United States-based company engaged in manufacturing of Saliva Glucose Biosensor (SGB). SGB uses saliva to measure glucose non-invasively. The Saliva Glucose Test consists of the SGB which is a single-use disposable saliva biosensor and the software app that interfaces the SGB with its digital information system.
Similar stocks
Find more stocks like INBS with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.